Tag: aaron gerds

QD-Myelofibrosis-GERDS
December 9, 2019/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

SM-guidelines_650x450
December 18, 2018/Research

NCCN Publishes Guidelines for Systemic Mastocytosis

How to care for patients with this rare, complex disease

chemo-drug_650x450
December 2, 2018/Research

The Next Step in Immunotherapy for Myeloid Hematologic Malignancies

Study explores atezolizumab for myelodysplastic syndrome

Spleen_650x450
September 25, 2018/Research

Try Ruxolitinib Again When Effectiveness Wanes in Myelofibrosis

Second (or third) time’s a charm in reducing splenomegaly and other symptoms

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

smart-phone_650x450
September 12, 2018/News & Insight

“Twitter Isn’t Just for Millennials.”

How one hematologist learned to use and value it

platelets_650x450
April 5, 2018/Research

How a Myelofibrosis Drug PERSISTed Through an FDA Hold

Final results of PERSIST-2 confirm benefit; PAC203 enrolling

red-blood-cells_650x450
December 9, 2017/Research

In Myelofibrosis, New Possibilities for Minimizing Symptoms and Drug Side Effects

JAK inhibitors, the hedgehog pathway and answers for anemia

ash16_650x450
December 6, 2016/Research

Pacritinib Outperforms Best Available Therapy for Myelofibrosis

Investigators working with FDA on safety signal

BackPage 1 of 1Next
Advertisement
Ad